financetom
Business
financetom
/
Business
/
Canada's Wajax Q3 revenue misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canada's Wajax Q3 revenue misses estimates
Nov 3, 2025 2:57 PM

Overview

* Wajax Q3 2025 revenue misses analyst expectations, despite a slight increase from 2024

* Adjusted EPS for Q3 2025 increased to C$0.75, reflecting margin improvement initiatives

* Company announced on Oct 15, CEO succession process, with completion expected in Q1 2026

Outlook

* In 2025, Wajax ( WJXFF ) expects strong demand in mining and energy sectors, supported by equipment backlog

* Company cites macroeconomic softness and Canada-U.S. trade uncertainty as challenges

* Wajax ( WJXFF ) focuses on inventory optimization, cost management, and margin improvement

Result Drivers

* MARGIN IMPROVEMENT - Gross profit margin increased due to higher margins in product support, industrial parts, and ERS sales

* COST CONTROL - Selling and administrative expenses remained flat as a percentage of revenue due to disciplined cost management

* INVENTORY OPTIMIZATION - Inventory reduction contributed to improved leverage ratio

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss C$483.1 C$512.4

Revenue mln mln (4

Analysts

)

Q3 C$0.75

Adjusted

EPS

Q3 EPS C$0.77

Q3 C$16.2

Adjusted mln

Net

Income

Q3 Gross 20.80%

Margin

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the heavy machinery & vehicles peer group is "buy."

* Wall Street's median 12-month price target for Wajax Corp ( WJXFF ) is C$25.50, about 2.5% above its October 31 closing price of C$24.87

* The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 9 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Txo Partners Insider Bought Shares Worth $1,905,020, According to a Recent SEC Filing
Txo Partners Insider Bought Shares Worth $1,905,020, According to a Recent SEC Filing
Dec 19, 2024
04:47 PM EST, 12/19/2024 (MT Newswires) -- Keith A Hutton, 10% Owner, Director, on December 17, 2024, executed a purchase for 120,000 shares in Txo Partners ( TXO ) for $1,905,020. Following the Form 4 filing with the SEC, Hutton has control over a total of 4,120,215 shares of the company, with 4,120,215 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1559432/000155943224000059/xslF345X05/wk-form4_1734644629.xml ...
SEC says aerospace firm AAR settles charges over bribing officials
SEC says aerospace firm AAR settles charges over bribing officials
Dec 19, 2024
WASHINGTON (Reuters) - The Securities and Exchange Commission said on Thursday that global aerospace company AAR Corp ( AIR ) agreed to resolve U.S. charges in connection with two bribery schemes related to Nepalese and South African officials. AAR agreed to pay about $30 million to settle the SEC's charges, the regulator said in a statement, adding that Deepak Sharma,...
OraSure Technologies Buys Sherlock Biosciences; Shares Rise After Hours
OraSure Technologies Buys Sherlock Biosciences; Shares Rise After Hours
Dec 19, 2024
04:45 PM EST, 12/19/2024 (MT Newswires) -- OraSure Technologies ( OSUR ) said late Thursday it acquired diagnostic health company Sherlock Biosciences. Financial details weren't disclosed. This acquisition enhances OraSure's ( OSUR ) innovation pipeline by adding Sherlock's molecular diagnostics platform, which delivers results with sensitivity and specificity in a disposable format ideal for over-the-counter use, the company said. Shares...
Cricut Insider Sold Shares Worth $320,608, According to a Recent SEC Filing
Cricut Insider Sold Shares Worth $320,608, According to a Recent SEC Filing
Dec 19, 2024
04:47 PM EST, 12/19/2024 (MT Newswires) -- Len Blackwell, Director, on December 17, 2024, sold 50,000 shares in Cricut ( CRCT ) for $320,608. Following the Form 4 filing with the SEC, Blackwell has control over a total of 1,458,047 shares of the company, with 1,458,047 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1828962/000182896224000135/xslF345X05/wk-form4_1734644635.xml ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved